table of content
1 Introduction to Research & Analysis Reports
1.1 Opioid Induced Constipation Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid Induced Constipation Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opioid Induced Constipation Drugs Overall Market Size
2.1 Global Opioid Induced Constipation Drugs Market Size: 2022 VS 2029
2.2 Global Opioid Induced Constipation Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Opioid Induced Constipation Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Opioid Induced Constipation Drugs Players in Global Market
3.2 Top Global Opioid Induced Constipation Drugs Companies Ranked by Revenue
3.3 Global Opioid Induced Constipation Drugs Revenue by Companies
3.4 Global Opioid Induced Constipation Drugs Sales by Companies
3.5 Global Opioid Induced Constipation Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Opioid Induced Constipation Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Opioid Induced Constipation Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Opioid Induced Constipation Drugs Players in Global Market
3.8.1 List of Global Tier 1 Opioid Induced Constipation Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Opioid Induced Constipation Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Opioid Induced Constipation Drugs Market Size Markets, 2022 & 2029
4.1.2 Lubiprostone
4.1.3 Methyl Naltrexone Bromide
4.1.4 Naldemedine
4.1.5 Alvimopan
4.1.6 Others
4.2 By Type - Global Opioid Induced Constipation Drugs Revenue & Forecasts
4.2.1 By Type - Global Opioid Induced Constipation Drugs Revenue, 2018-2023
4.2.2 By Type - Global Opioid Induced Constipation Drugs Revenue, 2024-2029
4.2.3 By Type - Global Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Opioid Induced Constipation Drugs Sales & Forecasts
4.3.1 By Type - Global Opioid Induced Constipation Drugs Sales, 2018-2023
4.3.2 By Type - Global Opioid Induced Constipation Drugs Sales, 2024-2029
4.3.3 By Type - Global Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Opioid Induced Constipation Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Opioid Induced Constipation Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Opioid Induced Constipation Drugs Revenue & Forecasts
5.2.1 By Application - Global Opioid Induced Constipation Drugs Revenue, 2018-2023
5.2.2 By Application - Global Opioid Induced Constipation Drugs Revenue, 2024-2029
5.2.3 By Application - Global Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Opioid Induced Constipation Drugs Sales & Forecasts
5.3.1 By Application - Global Opioid Induced Constipation Drugs Sales, 2018-2023
5.3.2 By Application - Global Opioid Induced Constipation Drugs Sales, 2024-2029
5.3.3 By Application - Global Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Opioid Induced Constipation Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Opioid Induced Constipation Drugs Market Size, 2022 & 2029
6.2 By Region - Global Opioid Induced Constipation Drugs Revenue & Forecasts
6.2.1 By Region - Global Opioid Induced Constipation Drugs Revenue, 2018-2023
6.2.2 By Region - Global Opioid Induced Constipation Drugs Revenue, 2024-2029
6.2.3 By Region - Global Opioid Induced Constipation Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Opioid Induced Constipation Drugs Sales & Forecasts
6.3.1 By Region - Global Opioid Induced Constipation Drugs Sales, 2018-2023
6.3.2 By Region - Global Opioid Induced Constipation Drugs Sales, 2024-2029
6.3.3 By Region - Global Opioid Induced Constipation Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Opioid Induced Constipation Drugs Revenue, 2018-2029
6.4.2 By Country - North America Opioid Induced Constipation Drugs Sales, 2018-2029
6.4.3 US Opioid Induced Constipation Drugs Market Size, 2018-2029
6.4.4 Canada Opioid Induced Constipation Drugs Market Size, 2018-2029
6.4.5 Mexico Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Opioid Induced Constipation Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Opioid Induced Constipation Drugs Sales, 2018-2029
6.5.3 Germany Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5.4 France Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5.5 U.K. Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5.6 Italy Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5.7 Russia Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Opioid Induced Constipation Drugs Market Size, 2018-2029
6.5.9 Benelux Opioid Induced Constipation Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Opioid Induced Constipation Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Opioid Induced Constipation Drugs Sales, 2018-2029
6.6.3 China Opioid Induced Constipation Drugs Market Size, 2018-2029
6.6.4 Japan Opioid Induced Constipation Drugs Market Size, 2018-2029
6.6.5 South Korea Opioid Induced Constipation Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Opioid Induced Constipation Drugs Market Size, 2018-2029
6.6.7 India Opioid Induced Constipation Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Opioid Induced Constipation Drugs Revenue, 2018-2029
6.7.2 By Country - South America Opioid Induced Constipation Drugs Sales, 2018-2029
6.7.3 Brazil Opioid Induced Constipation Drugs Market Size, 2018-2029
6.7.4 Argentina Opioid Induced Constipation Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Opioid Induced Constipation Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Opioid Induced Constipation Drugs Sales, 2018-2029
6.8.3 Turkey Opioid Induced Constipation Drugs Market Size, 2018-2029
6.8.4 Israel Opioid Induced Constipation Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Opioid Induced Constipation Drugs Market Size, 2018-2029
6.8.6 UAE Opioid Induced Constipation Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Ironwood Pharmaceuticals Inc
7.1.1 Ironwood Pharmaceuticals Inc Company Summary
7.1.2 Ironwood Pharmaceuticals Inc Business Overview
7.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Major Product Offerings
7.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Ironwood Pharmaceuticals Inc Key News & Latest Developments
7.2 Daiichi Sankyo Co Ltd
7.2.1 Daiichi Sankyo Co Ltd Company Summary
7.2.2 Daiichi Sankyo Co Ltd Business Overview
7.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Major Product Offerings
7.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Daiichi Sankyo Co Ltd Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Opioid Induced Constipation Drugs Major Product Offerings
7.3.4 Pfizer Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Progenics Pharmaceuticals Inc
7.4.1 Progenics Pharmaceuticals Inc Company Summary
7.4.2 Progenics Pharmaceuticals Inc Business Overview
7.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Major Product Offerings
7.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Progenics Pharmaceuticals Inc Key News & Latest Developments
7.5 Shionogi & Co., Ltd
7.5.1 Shionogi & Co., Ltd Company Summary
7.5.2 Shionogi & Co., Ltd Business Overview
7.5.3 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Major Product Offerings
7.5.4 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Shionogi & Co., Ltd Key News & Latest Developments
7.6 Allergan Plc
7.6.1 Allergan Plc Company Summary
7.6.2 Allergan Plc Business Overview
7.6.3 Allergan Plc Opioid Induced Constipation Drugs Major Product Offerings
7.6.4 Allergan Plc Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Allergan Plc Key News & Latest Developments
7.7 Nektar Therapeutics
7.7.1 Nektar Therapeutics Company Summary
7.7.2 Nektar Therapeutics Business Overview
7.7.3 Nektar Therapeutics Opioid Induced Constipation Drugs Major Product Offerings
7.7.4 Nektar Therapeutics Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Nektar Therapeutics Key News & Latest Developments
7.8 Purdue Pharma
7.8.1 Purdue Pharma Company Summary
7.8.2 Purdue Pharma Business Overview
7.8.3 Purdue Pharma Opioid Induced Constipation Drugs Major Product Offerings
7.8.4 Purdue Pharma Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Purdue Pharma Key News & Latest Developments
7.9 S.L.A. Pharma AG
7.9.1 S.L.A. Pharma AG Company Summary
7.9.2 S.L.A. Pharma AG Business Overview
7.9.3 S.L.A. Pharma AG Opioid Induced Constipation Drugs Major Product Offerings
7.9.4 S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.9.5 S.L.A. Pharma AG Key News & Latest Developments
7.10 Mundipharma International Limited
7.10.1 Mundipharma International Limited Company Summary
7.10.2 Mundipharma International Limited Business Overview
7.10.3 Mundipharma International Limited Opioid Induced Constipation Drugs Major Product Offerings
7.10.4 Mundipharma International Limited Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Mundipharma International Limited Key News & Latest Developments
7.11 Ono Pharmaceutical Co., Ltd
7.11.1 Ono Pharmaceutical Co., Ltd Company Summary
7.11.2 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Business Overview
7.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Major Product Offerings
7.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Ono Pharmaceutical Co., Ltd Key News & Latest Developments
7.12 Takeda Pharmaceutical Company Limited
7.12.1 Takeda Pharmaceutical Company Limited Company Summary
7.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Business Overview
7.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Major Product Offerings
7.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Takeda Pharmaceutical Company Limited Key News & Latest Developments
7.13 Theravance Biopharma Inc
7.13.1 Theravance Biopharma Inc Company Summary
7.13.2 Theravance Biopharma Inc Opioid Induced Constipation Drugs Business Overview
7.13.3 Theravance Biopharma Inc Opioid Induced Constipation Drugs Major Product Offerings
7.13.4 Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Theravance Biopharma Inc Key News & Latest Developments
7.14 Bausch Health
7.14.1 Bausch Health Company Summary
7.14.2 Bausch Health Business Overview
7.14.3 Bausch Health Opioid Induced Constipation Drugs Major Product Offerings
7.14.4 Bausch Health Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Bausch Health Key News & Latest Developments
7.15 Cosmo Pharmaceuticals SA
7.15.1 Cosmo Pharmaceuticals SA Company Summary
7.15.2 Cosmo Pharmaceuticals SA Business Overview
7.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Major Product Offerings
7.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Cosmo Pharmaceuticals SA Key News & Latest Developments
7.16 Daewoong Pharmaceutical
7.16.1 Daewoong Pharmaceutical Company Summary
7.16.2 Daewoong Pharmaceutical Business Overview
7.16.3 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Major Product Offerings
7.16.4 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Daewoong Pharmaceutical Key News & Latest Developments
7.17 C.B. Fleet Company
7.17.1 C.B. Fleet Company Company Summary
7.17.2 C.B. Fleet Company Business Overview
7.17.3 C.B. Fleet Company Opioid Induced Constipation Drugs Major Product Offerings
7.17.4 C.B. Fleet Company Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.17.5 C.B. Fleet Company Key News & Latest Developments
7.18 Sucampo Pharmaceuticals
7.18.1 Sucampo Pharmaceuticals Company Summary
7.18.2 Sucampo Pharmaceuticals Business Overview
7.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Major Product Offerings
7.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Sucampo Pharmaceuticals Key News & Latest Developments
8 Global Opioid Induced Constipation Drugs Production Capacity, Analysis
8.1 Global Opioid Induced Constipation Drugs Production Capacity, 2018-2029
8.2 Opioid Induced Constipation Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Opioid Induced Constipation Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Opioid Induced Constipation Drugs Supply Chain Analysis
10.1 Opioid Induced Constipation Drugs Industry Value Chain
10.2 Opioid Induced Constipation Drugs Upstream Market
10.3 Opioid Induced Constipation Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Opioid Induced Constipation Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
